Oxford Centre for Haematology
Director of the Centre
The OCH Management Board has as members the Director of the OCH, the Head of Clinical Haematology, the Head of Laboratory Haematology, the Head of the Radcliffe Department of Medicine, the Head of the Nuffield Division of Clinical Laboratory Sciences, the Director of the MRC Molecular Haematology Unit, the Director of the MRC Human Immunology Unit, the RDM Research Strategy Coordinator and the Administrator of the OCH.
Latest publications
-
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation.
Journal article
Crump NT. et al, (2021), Cell Rep, 35
-
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Journal article
Bernard E. et al, (2021), Nat Med
-
Single Cell Analysis Resolves Genetic and Transcriptional Heterogeneity in Myeloproliferative Neoplasms
Conference paper
Rodriguez-Meira A. et al, (2021), Experimental Hematology, 64
-
HYPOMETHYLATING AGENT IN A PATIENT WITH MDS/MPN-RS-T
Conference paper
Papadopoulou T. et al, (2021)
-
ACUTE MONOBLASTIC LEUKEMIA IN AN ELDERLY PATIENT WITH HEMOPHILIA A: A CASE REPORT
Conference paper
SOUSOS N. et al, (2021)
What's new
New funding for early diagnosis research using platelets
30 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Dr Noemi Roy awarded Medical Sciences Division public engagement seed funding
3 February 2021
Dr Noemi Roy has received funding in the 2020-21 round of the Public Engagement with Research Seed Fund as one of seven projects for innovative work to engage the public with medical research.
Understanding clonal haematopoiesis for COVID and cancer
30 September 2020
UPCOMING MEETINGS
28 June 2021: Oxford Centre for Haematology Annual Meeting
Please email for further information